Traynor Capital Management’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $218K | Buy |
98,100
+21,180
| +28% | +$47K | 0.02% | 225 |
|
|
2025
Q1 | $93.8K | Buy |
76,920
+21,250
| +38% | +$25.9K | 0.01% | 216 |
|
|
2024
Q4 | $71.8K | Buy |
55,670
+12,799
| +30% | +$16.5K | ﹤0.01% | 233 |
|
|
2024
Q3 | $118K | Hold |
42,871
| – | – | 0.01% | 222 |
|
|
2024
Q2 | $96.9K | Buy |
42,871
+8,164
| +24% | +$18.5K | 0.01% | 215 |
|
|
2024
Q1 | $83K | Hold |
34,707
| – | – | 0.01% | 218 |
|
|
2023
Q4 | $57.6K | Hold |
34,707
| – | – | 0.01% | 205 |
|
|
2023
Q3 | $66.6K | Buy |
+34,707
| New | +$66.6K | 0.01% | 186 |
|